Proportion Of Medicare Advantage & Commercial Populations Using Prescription Opioids Unchanged
After peaking in 2011 through 2012, the proportion of people filling any opioid prescription for populations covered by either commercial health insurance or Medicare Advantage plans, has remained nearly unchanged. Over the study period 2007 to 2016, annual opioid use prevalence was 14% for commercial beneficiaries, 26% for Medicare Advantage members age 65 and older, and 52% for Medicare Advantage members with disabilities under age 65.
These findings were reported in “Trends In Opioid Use In Commercially Insured And Medicare Advantage …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.